Digital Diagnostics

Digital Diagnostics is a medical-AI company best known for LumineticsCore (originally IDx-DR), which in 2018 became the first-ever FDA-authorized autonomous AI diagnostic — a system that makes a diagnostic decision without a physician interpreting the result. It analyzes retinal images to detect diabetic retinopathy, a leading cause of blindness that is preventable with early detection but often goes unscreened because it traditionally requires an eye specialist. By enabling the screening to happen in a primary-care or pharmacy setting with an automated read, LumineticsCore extends access to a sight-saving check. As the historic "first autonomous AI" cleared by the FDA, it is a landmark reference point for the entire field — its model of autonomous diagnosis in a narrow, well-validated task is the template regulators and developers study when weighing how much autonomy to grant medical AI.